AUCTORES
Globalize your Research
Chat with us
Research Article | DOI: https://doi.org/10.31579/2639-4162/063
1 Laboratory Department of the National Hospital Center of Nouakchott, Mauritania,
2 Faculty of Medicine of Nouakchott, Mauritania.
*Corresponding Author: Mohamed Lemine Ould Salem, Laboratory Service, National Hospital Center of Nouakchott, Mauritania, Microbiology Laboratory, Faculty of Medicine of Nouakchott.
Citation: Mohamed Lemine Ould Salem, El Hassen Ould Mohamed, Sidi Mohamed Ghaber (2022). Epidemiology and Sensitivity to Antibiotics of Enterobacteriaceae Producing Extended-Spectrum Beta-Lactamases (ESBL) in the Region of Nouakchott (Mauritania). J. General Medicine and Clinical Practice. 5(2); DOI:10.31579/2639-4162/063
Copyright: © 2022 Mohamed Lemine Ould Salem, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 17 May 2022 | Accepted: 27 May 2022 | Published: 03 June 2022
Keywords: enterobacteriaceae; extended-spectrum betalcatamase; antibiogram; nouakchott; mauritania
Introduction: Extended-spectrum beta-lactamases (ESBL) are a large heterogeneous family of bacterial enzymes discovered in 1980. They are induced either by plasmids or by mutation of the natural genome in the bacterium. Both mechanisms give affected bacteria the ability to hydrolyze a very wide variety of beta-lactams. (ESBL)-producing bacteria represent a major concern due to their epidemic spread and their multiresistance to antibiotics
The purpose of this study was to: determine their frequency of ESBL, know their distribution according to sex, hospital department, assess their levels of resistance to antibiotics and educate clinicians on the rational prescription of antibiotics.
Materials and Methods: This is a retrospective study which was carried out within the central laboratory of the National Hospital Center of Nouakchott (CHN) over two years. The antibiogram was carried out by the method of diffusion in agar medium or on the Vitek-2 automaton (Biomérieux®)
The production of ESBLs has been demonstrated by looking for a synergy between clavulanic acid and third-generation cephalosporins according to the usual techniques.
Results: Out of 650 species of Enterobacteriaceae, 18.46% produced ESBL, including 58% in hospitalized patients and 42% in outpatients. The ESBL resistance rate was high to quinolones, aminoglycosides (except amikacin) and cotrimoxazole, fosfomycin and carbapenems retain good activity.
Discussion: ESBLs are increasingly incriminated in both community-acquired and nosocomial infections and represent a real public health problem. In fact, 42% of ESBL isolated during our study came from outpatient consultations. This dissemination of ESBL in the community is alarming and could be explained, in part, by the anarchic use of antibiotics, it has also been mentioned by several studies.
Fosfomycin retains excellent efficacy against ESBL in our study with 90% sensitivity. The resistance of Enterobacteriaceae to carbapenems remained marginal with sensitivity rates of 98 to 100% , making them the best treatment against ESBL-producing Enterobacteriaceae. However, the misuse of these molecules has led to the emergence of resistance to these antibiotics, especially in certain enterobacteriaceae.
Conclusion: Considering the results of our study and the data from the literature, it clearly appears that ESBLs are taking an increasingly important place among multiresistant bacteria. The increase in resistance should be compared with the increase in antibiotic consumption.
These trends are problematic because they promote not only the emergence and spread of ESBL enterobacteriaceae, but also those of carbapenemase-producing enterobacteriaceae (CPE).
Faced with this worrying situation and given the increased risk of therapeutic impasse caused by these multi-resistant strains; very early detection of ESBL germ infections, isolation of patients carrying a transmissible infection and rational use of antibiotics should be carried out.
In the early 1960s, we witnessed an increase in the number of bacteria resistant to antibiotics, especially in hospitals, and the emergence of new resistances.
This is a major public health problem of great concern, affecting many countries, although resistant strains are often different from country to country [1].
The bacterium thus develops several strategies to resist the action of antibiotics:
The modification of the target of the antibiotic, the impermeability of the antibiotic, the enzymatic inactivation of the antibiotic…etc. The latter is done by the secretion of enzymes such as broad-spectrum beta-lactamases secreted by a number of bacteria and which inhibit almost the majority of beta-lactams which represent the largest family of antibiotics. [2].
Enterobacteriaceae are the most frequent cause of community and nosocomial infections.
Generally treated with beta-lactams, over the last few decades there has been an emergence of a very significant resistance of enterobacteriaceae to these antibiotics. [3].
Extended-spectrum beta-lactamases (ESBL) are a large heterogeneous family of bacterial enzymes discovered in 1980 in France and Germany. They are induced either by plasmids or by mutation of the natural genome in the bacterium. Both mechanisms give affected bacteria the ability to hydrolyze a very wide variety of beta-lactams.
The genetic mutations at the origin of (ESBL) broaden the spectrum of these enzymes and affect third-generation cephalosporins (ceftazidime and cefotaxime, etc.) and monobactams (aztreonam). ESBL-inducing bacteria do not hydrolyze cephamycins (cefoxitin) or carbapenems (imipenem) and they are inhibited by clavulanic acid, tazobactam and sulbactam representing classical beta-lactamase inhibitors [3,4].
Thus, we conducted a study on enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLE) isolated in the central laboratory of the National Hospital Center for 2 years from January 1, 2019 to December 31, 2020.
With the following objectives:
This is a retrospective study that was conducted within the central laboratory of the National Hospital Center of Nouakchott (CHN) over 2 years, from January 1, 2019 to December 31, 2020 on all bacteriological samples for diagnostic purposes received. at the central laboratory of Nouakchott Hospital Center (CHN) from hospitalized patients or outpatients.
The antibiogram was carried out by the agar diffusion method according to the recommendations of the EUCAST-CA-SFM of the current year, or on the Vitek-2 automaton (Biomérieux®)
The production of ESBLs has been demonstrated by looking for a synergy between clavulanic acid and third-generation cephalosporins according to the usual techniques.
| Strains | Number | Percentages |
| Escherichia coli | 400 | 61,54 % |
| Klebsiella pneumoniae | 120 | 18,46 % |
| Enterobacter cloacae | 80 | 12,31 % |
| Proteus mirabilis | 30 | 4,62 % |
| Salmonella enterica | 15 | 2,31 % |
| Enterobacter aerogenes | 4 | 0,62 % |
| Proteus peneri | 1 | 0,15 % |
| Total | 650 | 100 % |
Table 1: Percentage and number of species of Enterobacteriaceae isolates
2Distribution of ESBL-producing Enterobacteriaceae
The distribution of ESBL-producing strains is shown in Table 2
| species | Effective | Percentage |
| Escherichia coli | 30 | 25% |
| Klebsiella pneumoniae | 50 | 41.7% |
| Enterobacter cloacae | 15 | 12.5% |
| Proteus mirabilis | 10 | 8.3% |
| Salmonella enterica | 8 | 6.7% |
| Enterobacter aerogenes | 5 | 4.15 |
| Proteus peneri | 2 | 1.65 |
| Total | 120 | 100% |
Table 2: Distribution of ESBL-producing strains
3. Frequency of ESBL-producing Enterobacteriaceae
ESBL-producing Enterobacteriaceae (ESBL) during our study represents 18.46%.
4. Distribution of ESBLs according to patient gender:
Les entérobactéries productrices de ESBL (ESBLE) were predominant in the male sex (58%) against 42% in the female sex in our series.
5. Distribution of ESBLE strains by department:
The distribution of EBLSE according to the services is represented in table 3
| Service | Number | Percentage |
| Internal Medicine | 16 | 13.3% |
| Urology | 20 | 16.7% |
| Nephrology | 12 | 10.0% |
| General surgery | 10 | 8.3% |
| Outpatient consultation | 50 | 41.7% |
| Intensive care | 8 | 6.7% |
| Pediatrics | 4 | 3.3% |
| Total | 120 | 100% |
Table 3: Distribution of ESBLs by department
6. ESBL sensitivity to antibiotics:
The resistance profile of ESBL-producing strains to common antibiotics is shown in Table 4
| Antibiotic | Resistance | Sensitivity | ||
| Number | Percentage | Number | Percentage | |
| Amoxicillin | 120 | 100 % | 0 | 0 % |
| Amoxicillin + clavulanic acid | 12 | 10 % | 108 | 90 % |
| Ticarcillin | 120 | 100 % | 0 | 0% |
| Piperacillin | 120 | 100% | 0 | 0% |
| Cefalotin | 120 | 100 % | 0 | 0% |
| Cefoxitin | 0 | 0% | 120 | 100 % |
| Cefotaxime | 120 | 100 % | 0 | 0 % |
| Cefixime | 120 | 100 % | 0 | 0% |
| Nalidixic acid | 100 | 83,3 % | 20 | 16,7 % |
| Ofloxacin | 99 | 83 % | 21 | 17 % |
| Ciprofloxacin | 95 | 79 % | 25 | 21 % |
| Amikacin | 16 | 13 % | 104 | 87 % |
| Gentamicin | 95 | 79 % | 25 | 21 % |
| Tobramycin | 97 | 81 % | 23 | 19 % |
| Sulfamethoxazole-trimethoprim | 90 | 75 % | 30 | 25 % |
| Colistin | 12 | 5 % | 114 | 90 % |
| Fosfomycin | 12 | 10 % | 108 | 90 % |
| Imipenem | 4 | 3 % | 116 | 97 % |
Table 4: Resistance profile of ESBL-producing strains to antibiotics.
NB: -The percentage of resistance to colistin corresponds to the percentage of Proteus: natural resistance
- We have kept the old nomenclature of Enterobacteriaceae
Enterobacteriaceae producing broad-spectrum beta-lactams are diversely distributed according to continents, and within the same continent according to geographical areas [5,6].
(ESBL)-producing bacteria represent a major concern in the hospital environment because of their epidemic spread and their multidrug resistance to antibiotics.
The (ESBL) are obtained from a large proportion of gram-negative bacilli, but enterobacteriaceae are the most incriminated germs.
They are increasingly implicated in both community-acquired and nosocomial infections and represent a real public health problem.
Data collected by the National Hospital Center laboratory between 2019 and 2020 confirms that E coli is the species most encountered by all enterobacteriaceae as shown by many authors in Meknes [6], El Jadida [7], and Rabat [8].
Klebsiella pneumoniae is the most common ESBL-secreting Enterobacteriaceae, representing 58.33% of ESBL-secreting Enterobacteriaceae, followed by Escherichia coli representing 25% and then Enterobacter cloacae with 8.33%.
These rates remain close to those found in Rabat with 45%, 26%, 15% respectively [9], and in France with 59.2%, 20.2% and 11.8% respectively [10].
According to our study, the overall frequency of isolation of ESBL-producing Enterobacteriaceae is 18.46%. A Moroccan series showed a rate of 18.53% in Rabat [9]. Lower rates were reported in Europe: 2.6 and 2% [11,12].
Infections with extended-spectrum beta-lactam-producing enterobacteriaceae (ESBL) are more common in males than females.
This male predominance remains controversial, while studies have confirmed it [13,14], others have found a female predominance [15,16].
These differences may reflect regional disparities in gender-related antibiotic prescribing practices (Example: antibiotic therapy for cystitis in women).
Other authors report that male sex and transfer from a long-stay hospital are two major risk factors associated with ESBL carriage [17].
According to our study, patients over the age of 55 constituted the majority age group representing almost 75% of our sample. BMR) including EBLSE, figure an advanced age, generally over 65 years.
Forty-two percent (42%) of the ESBLs isolated during our study, come from outpatient consultations, this dissemination of ESBLs in the community is alarming and could be explained, in part, by the anarchic use of antibiotics, it has been mentioned by several studies [18].
In hospitals, a high frequency of ESBLs was noted in urology departments in our series (17%), probably related to the use of invasive devices (urinary catheter, etc.) and the use of multiple antibiotic therapy.
The ESBL rate in the surgery department (8%) is not negligible and could be related to the accumulation of surgical antibiotic prophylaxis and postoperative antibiotic therapy.
There is a consensus to try to eradicate urinary colonization in patients before undergoing urological surgery, or invasive explorations of the urinary tract.
It is a rule to also propose it during the placement of an osteo-articular, endo-vascular or heart valve prosthesis [19].
The distribution of (ESBL) according to the infectious sites, 60% of isolated ESBL-producing Enterobacteriaceae come from urinary tract infections. This rate remains high compared to other studies which report a predominance of ESBL from urinary tract infections [20].
Urinary tract infections are common conditions in daily practice. The essential causative agent is Escherichia coli since it is responsible for 50–80% of UTIs [21].
Resistance to Gram-negative bacteria has gained prominence lately.
years. Indeed, the Infectious Diseases Society of America (IDSA) recently identified six bacteria grouped under the name "ESKAPE" including Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species which are responsible for two-thirds of hospital-acquired infections, two-thirds of which are Gram-negative bacteria.
ESBLs are the most important threats by their frequency.
As a result, the WHO identifies this phenomenon as a major public health threat.
Beta-lactam resistance in BGNs can be caused by several
mechanisms, hydrolysis of the betalactam nucleus by the action of a betalactamase is the most frequent mechanism.
Over the past 70 years, the use of beta-lactams, including
new beta-lactams such as C3Gs and carbapenems, with a spectrum
increasingly broad action against BGNs, has selected betalactamase-type enzymes, each more powerful than the previous one.
Since 1983, transferable resistance to 3rd generation cephalosporins and monobactams in ESBLs has been disseminated in the majority of French hospitals [22].
These ESBLs derive for the majority of the enzymes TEM-1, TEM-2 and SHV by substitution of one or more amino acids; many types have been reported [23].
ESBL genes are usually carried by large transferable plasmids on which they are often associated with genes coding for resistance to aminoglycosides, chloramphenicol, sulfonamides, trimethoprim, cyclins and also fluoroquinolones [24].
In our study as in others, amikacin is less affected than gentamicin and tobramycin, but the rate of resistance to this molecule continues to increase due to its wide prescription [25].
The trimethoprim-sulfamethoxazole association has low activity on ESBL-producing enterobacteriaceae, with 25% sensitivity, this rate is 23% in Morocco and 25% in Iran [9,26]. A recent study in Benin found a resistance rate of 100%.
The ciprofloxacin resistance rate reported in our study is 79%. This rate is close to those reported by studies in Rabat, and in Switzerland with respective rates of 75% and 93% [9,27].
The massive use of fluoroquinolones for first-line treatment of urinary tract infections without prior documentation due to their broad bacterial spectrum and their good urinary diffusion could be responsible for this high rate of resistance.
Fosfomycin retains excellent efficacy against ESBL in our study, with 90% sensitivity.
The resistance of Enterobacteriaceae to carbapenems remained marginal with sensitivity rates of 98–100% [28], making carbapenems the best treatment for ESBL-producing Enterobacteriaceae [9]. Unfortunately, the misuse of these molecules has led to the emergence of resistance to these antibiotics, especially in Klebsiella pneumoniae [29].
In our study, the rate of resistance to imipenem is alarming, reaching 3% of isolates, so it is important to insist on the rational use of carbapenems in our country.
Similar resistance rates have been reported in Benin and Rabat with respective rates of 3.40% and 3.44% [26.30].
This decrease in sensitivity could be the result of a change in porins, associated with the production of ESBL-type beta-lactamases, therefore decreasing the permeability of the outer membrane [31], or even more alarmingly, the production of carbapenemases [32], making the treatment of ESBL infections very difficult and limiting treatment options [ 29].
Currently, there are no randomized and controlled studies for the treatment of ESBL infections.
Treatments with carbapenems (imipenem, meropenem, ertapenem) are burdened with the lowest mortality.
But the use of carbapenems, in the presence of ESBL, also promotes the emergence of other enzymes, the metallo-beta-lactamases which hydrolyze the carbapenems and render them ineffective. [33].
It should be noted that the carbapenems are not interchangeable and that there are ertapenem-resistant and imipenem-sensitive strains.
Today, it is appropriate to initiate a reflection on the molecules which could be used in the management of ESBL E infections, knowing already that none of the proposals can be ideal.
These are not recommendations or therapeutic strategies that have been validated today, but lines of research that could constitute avenues for study [34]:
The fight against the emergence of ESBLs is therefore a public health duty.
In a hospital environment, the diagnosis of colonization by ESBL is made by a smear from the perineum, inguinal or anal, given the probable digestive reservoir of this germ. In the community setting, there is no indication to perform screening smears.
In the presence of a patient colonized by an ESBL-producing germ, it is recommended to set up isolation measures, such as contact and individual room, in order to avoid nosocomial transmissions.
It is also recommended to limit the movements of carrier patients as much as possible in order to limit the risk of transmission to other patients [36 ].
The best prevention for this type of germ remains the rational prescription of broad-spectrum antibiotics aimed at reducing the selection pressure that can promote the emergence of ESBL-producing bacteria [ 37].
Our study made it possible to carry out a description of the epidemiological profile and the resistance of ESBL-producing enterobacteriaceae in the central laboratory of the National Hospital Center of Nouakchott between January 2019 and December 2020.
Considering the results of our study and the data from the literature, it clearly appears that ESBLs are taking an increasingly important place among multiresistant bacteria.
Indeed, almost three decades after their discovery, ESBLs initially confined in the years 1985 to the species K. pneumoniae during nosocomial infections in hospital intensive care units are now easily identified on a global scale.
Their involvement in nosocomial and community-acquired infections requires clinical, microbiological and therapeutic vigilance given their particular antibiotic resistance profile.
The increase in resistance should be compared with the increase in antibiotic consumption.
These trends are problematic because they promote not only the emergence and spread of ESBL enterobacteriaceae, but also those of carbapenemase-producing enterobacteriaceae (CPE).
Faced with this worrying situation and given the increased risk of therapeutic impasse caused by these multi-resistant strains; it is necessary to proceed to:
State of current knowledge on the subject
• E-ESBLs are multi-resistant bacteria with cross-resistance with other families other than beta-lactams
• The therapeutic management of ESBL-E infections poses a serious public health problem.
Contribution of our study to knowledge
• Our study is the first in Mauritania reserved for the prevalence of ESBL-E and their resistance to other common antibiotics
• It allowed us to highlight this high prevalence (18.46 %) of all enterobacteriaceae isolates over two years.
• It has demonstrated significant resistance to other families of antibiotics
• Carbapenems, fosfomycin, colistin and amikacin still retain good activity on these strains.
Conflicts of interest
The authors declare no conflict of interest.
Author contributions
All authors contributed to the conduct of this work.
All authors declare to have read and approved the final version of the manuscript.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
